- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 5, 2026 | 29.66M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 29.8M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 30.47M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $3.86M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $62.39M |
| Capex | Q1 2026 · Mar 31, 2026 | $6M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $10.76M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$41.17M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $13.68M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $1.22B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $0 |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $0 |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $20.35M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $115.72M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $880.63M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $950.4M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $1.01B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $1.05B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $497.34M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $366.02M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $699.71M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $628.89M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $2.79B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.39B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$2.26 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.69 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$2.26 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.70 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $83.33M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $41.2M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$67.47M |
| Net Income | Q1 2026 · Mar 31, 2025 | $21.12M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$4.46M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $28.66M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $78.87M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $69.85M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $277.42M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $176.5M |
| Revenue | Q1 2026 · Mar 31, 2026 | $356.29M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $246.36M |